Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6226 AL 6240

The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

Wang LL, Huang Y, Wang G, Chen SD.

Med Hypotheses. 2012 Mar;78(3):398-401. doi: 10.1016/j.mehy.2011.11.019. Epub 2011 Dec 29.

Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets

Lee VM, Brunden KR, Hutton M, Trojanowski JQ.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006437. doi: 10.1101/cshperspect.a006437.

New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease?

Hölscher C, Li L.

Neurobiol Aging. 2010 Sep;31(9):1495-502. doi: 10.1016/j.neurobiolaging.2008.08.023. Epub 2008 Oct 18.

[The amount of professional nursing care in a gerontopsychiatric hospital--comparison of the system of the psychiatry personnel act and the long-term care insurance]

Noelle DR, Schulz M, Behrens J, Driessen M.

Gesundheitswesen. 2010 Apr;72(4):233-9. doi: 10.1055/s-0029-1215566. Epub 2009 Jun 16.

Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer disease clinical trials

Carr SA, Davis R, Spencer D, Smart M, Hudson J, Freeman S, Cooper GE, Schmitt FA, Markesbery WR, Danner D, Jicha GA.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):165-70. doi: 10.1097/WAD.0b013e3181aba927.

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors

Brunden KR, Ballatore C, Crowe A, Smith AB 3rd, Lee VM, Trojanowski JQ.

Exp Neurol. 2010 Jun;223(2):304-10. doi: 10.1016/j.expneurol.2009.08.031. Epub 2009 Sep 8.

Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention

Dasilva KA, Shaw JE, McLaurin J.

Exp Neurol. 2010 Jun;223(2):311-21. doi: 10.1016/j.expneurol.2009.08.032. Epub 2009 Sep 8.

Valproic acid as a promising agent to combat Alzheimer's disease

Zhang XZ, Li XJ, Zhang HY.

Brain Res Bull. 2010 Jan 15;81(1):3-6. doi: 10.1016/j.brainresbull.2009.09.003.

Inflammation and anti-inflammatory strategies for Alzheimer's disease--a mini-review

McNaull BB, Todd S, McGuinness B, Passmore AP.

Gerontology. 2010;56(1):3-14. doi: 10.1159/000237873. Epub 2009 Sep 10.

The brain RAS and Alzheimer's disease

Wright JW, Harding JW.

Exp Neurol. 2010 Jun;223(2):326-33. doi: 10.1016/j.expneurol.2009.09.012. Epub 2009 Sep 24.

Cholesterol and statins in Alzheimer's disease: current controversies

Fonseca AC, Resende R, Oliveira CR, Pereira CM.

Exp Neurol. 2010 Jun;223(2):282-93. doi: 10.1016/j.expneurol.2009.09.013. Epub 2009 Sep 25.

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Wiig EH, Annas P, Basun H, Andreasen N, Lannfelt L, Zetterberg H, Blennow K, Minthon L.

Acta Neurol Scand. 2010 Mar;121(3):186-93. doi: 10.1111/j.1600-0404.2009.01160.x. Epub 2009 Sep 24.

Searching for new animal models of Alzheimer's disease

Epis R, Gardoni F, Marcello E, Genazzani A, Canonico PL, Di Luca M.

Eur J Pharmacol. 2010 Jan 10;626(1):57-63. doi: 10.1016/j.ejphar.2009.10.020. Epub 2009 Oct 15.

Depression and Alzheimer's disease: neurobiological links and common pharmacological targets

Caraci F, Copani A, Nicoletti F, Drago F.

Eur J Pharmacol. 2010 Jan 10;626(1):64-71. doi: 10.1016/j.ejphar.2009.10.022. Epub 2009 Oct 18.

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease

Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A.

Psychopharmacology (Berl). 2010 Jan;207(4):637-43. doi: 10.1007/s00213-009-1706-1. Epub 2009 Oct 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias